Keiichiro Matoba

1.5k total citations
41 papers, 1.2k citations indexed

About

Keiichiro Matoba is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Keiichiro Matoba has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Nephrology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Keiichiro Matoba's work include Chronic Kidney Disease and Diabetes (10 papers), Metabolism, Diabetes, and Cancer (9 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Keiichiro Matoba is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Metabolism, Diabetes, and Cancer (9 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Keiichiro Matoba collaborates with scholars based in Japan, United States and Ireland. Keiichiro Matoba's co-authors include Kazunori Utsunomiya, Daiji Kawanami, Tamotsu Yokota, Yosuke Nagai, Yusuke Takeda, Rimei Nishimura, Yasushi Kanazawa, Sho Ishizawa, Kazunori Sango and Yusuke Takeda and has published in prestigious journals such as PLoS ONE, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Keiichiro Matoba

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichiro Matoba Japan 18 480 385 337 166 154 41 1.2k
Tamotsu Yokota Japan 21 589 1.2× 338 0.9× 315 0.9× 184 1.1× 127 0.8× 37 1.4k
Xiaofen Xiong China 16 592 1.2× 285 0.7× 135 0.4× 123 0.7× 232 1.5× 22 1.2k
Xuejing Zhu China 20 701 1.5× 478 1.2× 144 0.4× 169 1.0× 267 1.7× 34 1.5k
Markus Lassila Finland 21 490 1.0× 309 0.8× 412 1.2× 182 1.1× 91 0.6× 34 1.5k
Hisazumi Araki Japan 18 422 0.9× 368 1.0× 220 0.7× 225 1.4× 380 2.5× 27 1.2k
Satish RamachandraRao United States 12 417 0.9× 493 1.3× 200 0.6× 168 1.0× 275 1.8× 14 1.3k
Hitomi Usui Japan 13 444 0.9× 659 1.7× 369 1.1× 249 1.5× 297 1.9× 14 1.6k
Meenalakshmi M. Mariappan United States 20 838 1.7× 332 0.9× 138 0.4× 200 1.2× 119 0.8× 26 1.4k
Kosuke Yamahara Japan 15 392 0.8× 395 1.0× 277 0.8× 248 1.5× 399 2.6× 25 1.2k
Koji Kuboki Japan 10 505 1.1× 275 0.7× 440 1.3× 212 1.3× 181 1.2× 22 1.5k

Countries citing papers authored by Keiichiro Matoba

Since Specialization
Citations

This map shows the geographic impact of Keiichiro Matoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichiro Matoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichiro Matoba more than expected).

Fields of papers citing papers by Keiichiro Matoba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichiro Matoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichiro Matoba. The network helps show where Keiichiro Matoba may publish in the future.

Co-authorship network of co-authors of Keiichiro Matoba

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichiro Matoba. A scholar is included among the top collaborators of Keiichiro Matoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichiro Matoba. Keiichiro Matoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matoba, Keiichiro, Yosuke Nagai, Shinji Ohashi, et al.. (2024). Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis. Communications Biology. 7(1). 402–402. 3 indexed citations
3.
Matoba, Keiichiro, Yosuke Nagai, Shoji Nagao, et al.. (2024). Rho-associated, coiled-coil-containing protein kinase 2 regulates expression of mineralocorticoid receptor to mediate sodium reabsorption in mice. Biochemical and Biophysical Research Communications. 736. 150874–150874. 1 indexed citations
4.
Matoba, Keiichiro. (2023). Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap. Endocrine Journal. 70(8). 771–776. 2 indexed citations
5.
Matoba, Keiichiro. (2022). Monitoring Leukocyte Migration During Atherosclerosis In Vivo. Methods in molecular biology. 2419. 475–479. 3 indexed citations
6.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2022). ROCK2-induced metabolic rewiring in diabetic podocytopathy. Communications Biology. 5(1). 341–341. 11 indexed citations
7.
Nagai, Yosuke, Keiichiro Matoba, Yusuke Takeda, et al.. (2022). Rho-associated, coiled-coil–containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism. Kidney International. 102(3). 536–545. 16 indexed citations
8.
Murakami, Kentaro, et al.. (2021). Effects of individualized dietary advice compared with conventional dietary advice for adults with type 2 diabetes: A randomized controlled trial. Nutrition Metabolism and Cardiovascular Diseases. 32(4). 1035–1044. 6 indexed citations
9.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2020). The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease. Frontiers in Pharmacology. 11. 585633–585633. 23 indexed citations
10.
Matoba, Keiichiro, Yusuke Takeda, Yosuke Nagai, et al.. (2020). Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease. Biomedicines. 8(2). 40–40. 38 indexed citations
11.
Han, Shuxin, Preeti Pathak, David R. Sweet, et al.. (2019). KLF15 regulates endobiotic and xenobiotic metabolism. Nature Metabolism. 1(4). 422–430. 16 indexed citations
12.
Takaku, Shizuka, Mari Suzuki, Naoko Niimi, et al.. (2019). Glycolaldehyde induces sensory neuron death through activation of the c-Jun N-terminal kinase and p-38 MAP kinase pathways. Histochemistry and Cell Biology. 153(2). 111–119. 11 indexed citations
13.
Takeda, Yusuke, Keiichiro Matoba, Daiji Kawanami, Yosuke Nagai, & Kazunori Utsunomiya. (2019). 426-P: ROCK2 Regulates Monocytic Migration and Cell-to-Cell Adhesion in Vascular Endothelial Cells. Diabetes. 68(Supplement_1). 1 indexed citations
14.
Nagai, Yosuke, Daiji Kawanami, Keiichiro Matoba, et al.. (2018). Rho-Kinase Induces CTGF Expression through Actin Dynamics in Mesangial Cells. Diabetes. 67(Supplement_1). 1 indexed citations
15.
Matoba, Keiichiro, Daiji Kawanami, Jun Kinoshita, et al.. (2014). Rho-kinase regulation of TNF-α-induced nuclear translocation of NF-κB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells. American Journal of Physiology-Renal Physiology. 307(5). F571–F580. 42 indexed citations
16.
Ishizawa, Sho, Junko Takahashi‐Fujigasaki, Yasushi Kanazawa, et al.. (2014). Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clinical and Experimental Nephrology. 18(6). 844–852. 34 indexed citations
17.
Kawanami, Daiji, Keiichiro Matoba, Rina Okada, et al.. (2013). Fasudil inhibits ER stress-induced VCAM-1 expression by modulating unfolded protein response in endothelial cells. Biochemical and Biophysical Research Communications. 435(2). 171–175. 14 indexed citations
18.
Kanazawa, Yasushi, Junko Takahashi‐Fujigasaki, Sho Ishizawa, et al.. (2013). The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells. Experimental Neurology. 247. 438–446. 21 indexed citations
19.
Matoba, Keiichiro, Daiji Kawanami, Rina Okada, et al.. (2013). Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney International. 84(3). 545–554. 80 indexed citations
20.
Utsunomiya, Kazunori, Sho Ishizawa, Yasushi Kanazawa, et al.. (2009). Association of Polymorphism of Estrogen Receptor-.ALPHA. Gene with Circulating Levels of Adiponectin in Postmenopausal Women with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 16(3). 250–255. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamotsu Yokota Breakdown of academic impact, for papers by Xiaofen Xiong Breakdown of academic impact, for papers by Xuejing Zhu Breakdown of academic impact, for papers by Markus Lassila Breakdown of academic impact, for papers by Hisazumi Araki Breakdown of academic impact, for papers by Satish RamachandraRao Breakdown of academic impact, for papers by Hitomi Usui Breakdown of academic impact, for papers by Meenalakshmi M. Mariappan Breakdown of academic impact, for papers by Kosuke Yamahara Breakdown of academic impact, for papers by Koji Kuboki
Rankless by CCL
2026